Filing Details

Accession Number:
0001209191-21-071563
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-12-29 20:44:11
Reporting Period:
2021-12-28
Accepted Time:
2021-12-29 20:44:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
879407 Arrowhead Pharmaceuticals Inc. ARWR Pharmaceutical Preparations (2834) 460408024
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1156207 B Douglas Given 177 E. Colorado Blvd
Suite 700
Pasadena CA 91105
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-12-28 655 $0.00 109,213 No 5 G Direct
Common Stock Acquisiton 2021-12-28 655 $66.37 109,868 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 G Direct
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 13,875 Indirect By Trust
Common Stock 12,500 Indirect By Trust
Footnotes
  1. Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions.
  2. Represents securities owned directly by Anne Given Trust ("AG Trust"). Mr. Given, as co-trustee of AG Trust, may be deemed to beneficially own the securities owned directly by AG Trust.
  3. Represents securities owned directly by Katherine Given Ligtenberg Trust ("KGL Trust"). Mr. Given, as co-trustee of KGL Trust, may be deemed to beneficially own the securities owned directly by KGL Trust.